Jonathan Young, Chief Operating Officer at Akero Therapeutics, Inc. (AKRO), sold 2,906 shares at $54.84 ($159K) on 2025-06-18, disclosed to the SEC on 2025-06-20.
Open-market sale of $159k AKRO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.84 | 1,453 | $80K | 50.0% |
| 2 | $54.84 | 1,453 | $80K | 50.0% |
| Total | $54.84 avg | 2,906 | $159K | 100% |
| Filing → |
| AKRO | SELL | 2025-09-04 | $705K | — | Filing → |
| AKRO | SELL | 2025-08-13 | $1.2M | — | Filing → |
| AKRO | SELL | 2025-06-12 | $269K | — | Filing → |